Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds IO Biotech Q3 EPS $(0.56)

IO Biotech Q3 EPS $(0.56)

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.56) per share.

byBill Haddad

November 9, 2022

1 minute read

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.56) per share.

Cowen & Co. Maintains Outperform on REE Automotive, Lowers Price Target to $6

By Benzinga Newsdesk

November 17, 10:34 AM

Cowen & Co. analyst Jeffrey Osborne maintains REE Automotive (NASDAQ:REE) with a Outperform and lowers the price target from $7.5 to $6.

REE

Why Wearable Devices (WLDS) Stock Is Down Over 50%

By Henry Khederian

November 9, 11:10 AM

Wearable Devices Ltd (NASDAQ: WLDS) shares are trading lower by 54% to $0.43 Thursday morning after the company announced a public offering of 4,444,444 ordinary shares at a price of

WLDS

Keybanc Maintains Overweight on Match Group, Lowers Price Target to $82

By Benzinga Newsdesk

August 4, 4:31 AM

Keybanc analyst Justin Patterson maintains Match Group (NASDAQ:MTCH) with a Overweight and lowers the price target from $90 to $82.

MTCH

Shiba Inu Lead Developer Says Much-Awaited Shibarium To Launch In August, BONE Spikes 5%

By Mehab Qureshi

July 7, 6:09 AM

Shiba Inu (CRYPTO: SHIB) ecosystem lead developer Shytoshi Kusama on Thursday announced plans for the launch of the much-anticipated Shibarium, a layer 2 blockchain solution.

$BONE

IO Biotech Q3 EPS $(0.56)

Related Posts

Cowen & Co. Maintains Outperform on REE Automotive, Lowers Price Target to $6

Why Wearable Devices (WLDS) Stock Is Down Over 50%

Keybanc Maintains Overweight on Match Group, Lowers Price Target to $82

Shiba Inu Lead Developer Says Much-Awaited Shibarium To Launch In August, BONE Spikes 5%